HSPG2 and neoplasm: As regards extracellular matrix PGs, no significant differences in levels of agrin were found (Fig. 1a and b), although transcription levels of perlecan decreased in about 75% of tumor samples (p < 0.05), with values being around 60% lower than those obtained for healthy tissues (Fig. 1c).